Balyasny Asset Management
NEUE

Balyasny Asset Management’s NeueHealth NEUE Stock Holding History

Balyasny Asset Management’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-457
Closed -$23.8K – 3234
2022
Q4 		$23.8K Buy
+457
New +$33.2K ﹤0.01% 2461

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management's NEUE Position: Q1 2023 in Review

Balyasny Asset Management sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 457 shares — an estimated $23.8K sold.

Balyasny Asset Management first reported a position in NEUE in Q4 2022 and held it in 1 quarter. The position peaked at $23.8K in Q4 2022. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

  • Balyasny Asset Management reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 457 NeueHealth shares in Q1 2023, an estimated $23.8K.
  • Balyasny Asset Management first reported a position in NeueHealth in Q4 2022 and held it in 1 quarter.
  • Balyasny Asset Management's NeueHealth position peaked at $23.8K in Q4 2022.
  • 108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.